首页> 美国卫生研究院文献>Nutrients >Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children
【2h】

Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children

机译:小儿肠衰竭相关性肝病的防治

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intestinal failure-associated liver disease (IFALD) is a threatening complication for children on long-term parenteral nutrition because of intestinal failure. When progressive and intractable, it may jeopardize intestinal rehabilitation and lead to combined liver and intestinal transplantation. The institution of dedicated intestinal failure centers has dramatically decreased the incidence of such complication. IFALD may rapidly fade away if very early management aimed at preventing progression to end-stage liver disease is provided. In this review, we address the etiology and risk factors of IFALD in order to introduce pillars of prevention (nutritional management and catheter-related infections control). The latest evidence of therapeutic strategies, such as medical and surgical treatments, is also discussed.
机译:与肠道衰竭相关的肝病(IFALD)对于因肠道衰竭而长期接受肠外营养的儿童来说,是一种威胁性并发症。当进行性和顽固性时,它可能会危害肠的康复,并导致肝脏和肠的联合移植。专门的肠衰竭中心机构大大减少了这种并发症的发生。如果提供非常早期的预防旨在发展为晚期肝病的早期治疗方法,IFALD可能会迅速消失。在这篇综述中,我们介绍了IFALD的病因和危险因素,以介绍预防的基础(营养管理和与导管相关的感染控制)。还讨论了治疗策略的最新证据,例如医学和外科治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号